Winway Health Desk
NICE shuns Novo Nordisk’s obesity med Saxenda, citing CV questions
Novo Nordisk bet big on its GLP-1 med Saxenda in obesity, despite rivals' failures to expand the global market. But payers in England have put...
Outcome-based contracts likely to keep growing, evolving despite challenges
Agreements between drugmakers and payers under which reimbursement is contingent on specific outcomes have been a hot topic in healthcare for several years, but...
Pfizer challenges Roche blockbusters with 3 biosim launches at discounts from...
Pfizer hit some unexpected roadblocks with its first U.S. biosimilar launch, but it’s not giving up in the budding field. Now, the drugmaker is launching biosims to...
Epizyme gets accelerated approval for drug to treat rare sarcoma
The Food and drug Administration has approved the first drug for a rare form of connective-tissue cancer.
Cambridge, Massachusetts-based Epizyme said Thursday that the FDA...
Epizyme scores FDA nod for rare cancer med Tazverik, but prices...
On the heels of a unanimous FDA panel vote last month in favor of its application, Epizyme’s rare cancer med Tazverik scored U.S. approval Thursday.
Tazverik won approval to treat...
PHOTO TOUR: Beaumont Hospital, Royal Oak, Emergency Center Expansion
Facing an influx of patients that strained space, staff, and resources at Beaumont Hospital, Royal Oak, owner Beaumont Health set out to redesign its...
FiercePharmaAsia—Amgen-Astellas JV; Hengrui’s new chairman; coronavirus vaccine development
On the heels of a China team-up with BeiGene, Amgen is on track to run a Japanese operation independently after buying out an Astellas...
Face Time: Renaldo Pesson
With a career that spans more than two decades, Renaldo Pesson has worked in a variety of design sectors, including commercial, institutional, and healthcare....
Faced with slowing demand, 23andMe cuts 100 employees
Consumer DNA testing company 23andMe will cut about 100 employees, with fewer users buying its at-home testing kits. A company spokeswoman confirmed 23andMe had...
FDA clears smart inhaler cap from Cognita Labs
Santa Ana, California-based startup Cognita Labs has won FDA clearance for its first device, a smart cap for inhalers used by people with asthma,...
